Urinary Excretion of Biomolecules Related to Cell Cycle, Proliferation, and Autophagy in Subjects with Type 2 Diabetes and Chronic Kidney Disease

Anton I. Korbut,Vyacheslav V. Romanov,Vadim V. Klimontov
DOI: https://doi.org/10.3390/biomedicines12030487
IF: 4.757
2024-02-22
Biomedicines
Abstract:Dysregulation of cell cycle, proliferation, and autophagy plays a pivotal role in diabetic kidney disease. In this study, we assessed urinary excretion of molecular regulators of these processes that mediate their effects via the PI3K/AKT/mTOR pathway in subjects with long-term type 2 diabetes (T2D) and different patterns of chronic kidney disease (CKD). We included 140 patients with T2D and 20 non-diabetic individuals in a cross-sectional study. Urinary PTEN, Beclin-1, sirtuin 1 (SIRT1), Klotho, fibroblast growth factor 21 (FGF21), and connective tissue growth factor (CTGF) were assessed using ELISA. Patients with T2D, when compared to control, demonstrated increased excretion of PTEN, Beclin-1, SIRT1, FGF21, CTGF, and decreased urinary Klotho (all p < 0.05). In the diabetic group, PTEN, FGF21, and CTGF were significantly higher in patients with declined renal function, while Klotho was lower in those with elevated albuminuria. FGF21 and PTEN correlated inversely with the estimated glomerular filtration rate. There was a negative correlation between Klotho and urinary albumin-to-creatinine ratio. In multivariate models, Klotho and PTEN were associated with albuminuric CKD independently. The results provide further support for the role of PTEN, BECN1, FGF21, Klotho, and CTGF in development albuminuric and non-albuminuric CKD in diabetes.
biochemistry & molecular biology,medicine, research & experimental,pharmacology & pharmacy
What problem does this paper attempt to address?
The problem that this paper attempts to solve is the urinary excretion of biomolecules related to the cell cycle, proliferation and autophagy (such as PTEN, BECN1, SIRT1, Klotho, FGF21 and CTGF) in patients with type 2 diabetes (T2D) and chronic kidney disease (CKD), as well as the roles and associations of these biomolecules in different CKD phenotypes. Specifically, the study aims to explore whether these molecules can be used as potential biomarkers for albuminuric and non - albuminuric CKD in T2D patients. ### Research Background - **Global Trend**: The prevalence of chronic kidney disease (CKD) and type 2 diabetes (T2D) is continuously increasing worldwide. - **Disease Burden**: CKD caused by T2D and hypertension accounts for the largest disease burden, and 85% of cases are caused by these two diseases. - **Molecular Mechanism**: Diabetic nephropathy is related to the dysregulation of the cell cycle, proliferation and autophagy, and these processes are mainly mediated by the PI3K/AKT/mTOR signaling pathway. ### Research Objectives - **Evaluate Urinary Biomolecules**: Evaluate the urinary excretion of biomolecules (PTEN, BECN1, SIRT1, Klotho, FGF21 and CTGF) related to the cell cycle, proliferation and autophagy in T2D patients. - **Explore Associations**: Explore the roles and associations of these biomolecules in different CKD phenotypes (such as albuminuric and non - albuminuric CKD). - **Potential Biomarkers**: Determine whether these biomolecules can be used as potential biomarkers for albuminuric and non - albuminuric CKD in T2D patients. ### Main Findings - **Urinary PTEN**: The urinary PTEN excretion in T2D patients is increased and is associated with decreased renal function and increased albuminuria. - **Urinary BECN1**: The urinary BECN1 excretion in T2D patients is increased, especially in non - albuminuric CKD patients. - **Urinary Klotho**: The urinary Klotho excretion in T2D patients is decreased and is associated with increased albuminuria. - **Urinary FGF21 and CTGF**: The urinary FGF21 and CTGF excretion in T2D patients is increased and is associated with decreased renal function. ### Discussion - **PTEN**: PTEN is an inhibitor of the PI3K/AKT/mTOR signaling pathway, and the increase in its urinary excretion may be related to renal cell damage. - **BECN1**: BECN1 is a key regulator of autophagy, and the increase in its urinary excretion may be the result of renal cell damage. - **Klotho**: Klotho has a renal - protective effect, and the decrease in its urinary excretion is associated with increased albuminuria, which may be because albumin directly reduces the expression of Klotho. - **FGF21**: FGF21 is generally considered as a protective factor in diabetes, and the increase in its urinary excretion is associated with decreased renal function. ### Conclusion This study provides further support, indicating that PTEN, BECN1, FGF21, Klotho and CTGF play important roles in the development of albuminuric and non - albuminuric CKD in T2D patients. These biomolecules may become potential biomarkers for evaluating and monitoring these diseases.